Guy Young/LinkedIn;
Mark T. Reding/emedevents.com/
Mar 12, 2026, 11:50
Guy Young: Clinical Conversations on Gene Therapy Progress in Hemophilia B at THSNA 2026
Guy Young, Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles, shared a post on LinkedIn:
“I’m looking forward to speaking at THSNA 2026 on Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery.
Join Mark T. Reding, MD and I as we discuss:
- Clarifying the role of gene therapy in hemophilia B within an evolving treatment landscape
- Improving patient selection and counseling in real-world practice
- Operationalizing delivery – from referral coordination to infusion management, monitoring, and long-term follow-up across care settings
This symposium will take place live in person on March 21 at 6:45 AM PDT at the Oregon Convention Center in Portland during the THSNA 2026 Annual Meeting, with a live virtual program to follow on March 30 at 7:00 PM EDT.
Other posts featuring Guy Young on Hemostasis Today.
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025